These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 34129730)

  • 1. Alopecia areata severity index (AASI): A reliable scoring system to assess the severity of alopecia areata on face and scalp-a pilot study.
    Majid I; Sameem F; Sultan J; Aleem S
    J Cosmet Dermatol; 2021 Aug; 20(8):2565-2570. PubMed ID: 34129730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alopecia Areata Progression Index, a Scoring System for Evaluating Overall Hair Loss Activity in Alopecia Areata Patients with Pigmented Hair: A Development and Reliability Assessment.
    Jang YH; Moon SY; Lee WJ; Lee SJ; Lee WK; Park BC; Kim H; Kim DW
    Dermatology; 2016; 232(2):143-9. PubMed ID: 26757319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Alopecia Areata Severity and Morbidity Index (ASAMI) Study: Results From a Global Expert Consensus Exercise on Determinants of Alopecia Areata Severity.
    ; Moussa A; Bennett M; Wall D; Meah N; York K; Bokhari L; Asfour L; Rees H; Abraham LS; Asz-Sigall D; Basmanav FB; Bergfeld W; Betz RC; Bhoyrul B; Blume-Peytavi U; Callender V; Chitreddy V; Combalia A; Cotsarelis G; Craiglow B; Dhurat R; Donovan J; Doroshkevich A; Eisman S; Farrant P; Ferrando J; Gadzhigoroeva A; Green J; Grimalt R; Harries M; Hordinsky M; Irvine A; Jolliffe V; Kaiumov S; King B; Lee J; Lee WS; Li J; Lortkipanidze N; McMichael A; Mesinkovska NA; Messenger A; Mirmirani P; Olsen E; Orlow SJ; Ovcharenko Y; Piraccini BM; Pirmez R; Rakowska A; Reygagne P; Rudnicka L; Corralo DS; Senna M; Shapiro J; Sharma P; Siliuk T; Starace M; Suchonwanit P; Takwale A; Tosti A; Vañó-Galván S; Visser WI; Vogt A; Wade M; Yip L; Zhou C; Sinclair R
    JAMA Dermatol; 2024 Mar; 160(3):341-350. PubMed ID: 38324292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermatologist and Patient Perceptions of Treatment Success in Alopecia Areata and Evaluation of Clinical Outcome Assessments in Japan.
    Macey J; Kitchen H; Aldhouse NVJ; Burge RT; Edson-Heredia E; McCollam JS; Isaka Y; Torisu-Itakura H
    Dermatol Ther (Heidelb); 2021 Apr; 11(2):433-447. PubMed ID: 33464474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials.
    Wyrwich KW; Kitchen H; Knight S; Aldhouse NVJ; Macey J; Nunes FP; Dutronc Y; Mesinkovska N; Ko JM; King BA
    Br J Dermatol; 2020 Oct; 183(4):702-709. PubMed ID: 31970750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2).
    Kwon O; Senna MM; Sinclair R; Ito T; Dutronc Y; Lin CY; Yu G; Chiasserini C; McCollam J; Wu WS; King B
    Am J Clin Dermatol; 2023 May; 24(3):443-451. PubMed ID: 36855020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eyebrows Are Important in the Treatment of Alopecia Areata.
    Liu LY; King BA; Ko JM
    J Investig Dermatol Symp Proc; 2020 Nov; 20(1):S37-S40. PubMed ID: 33099382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Patients in Alopecia Areata Endpoint Development: Understanding Physical Signs and Symptoms.
    Wyrwich KW; Kitchen H; Knight S; Aldhouse NVJ; Macey J; Nunes F; Dutronc Y; Mesinkovska NA; Ko JM; King BA
    J Investig Dermatol Symp Proc; 2020 Nov; 20(1):S71-S77. PubMed ID: 33099392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Alopecia Areata Patient Priority Outcomes (AAPPO) Questionnaire in Adults and Adolescents with Alopecia Areata.
    Wyrwich KW; Winnette R; Bender R; Gandhi K; Williams N; Harris N; Nelson L
    Dermatol Ther (Heidelb); 2022 Jan; 12(1):149-166. PubMed ID: 34846634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using qualitative methods to establish the clinically meaningful threshold for treatment success in alopecia areata.
    Wyrwich KW; Kitchen H; Knight S; Aldhouse NVJ; Macey J; Mesinkovska N; Ko JM; King BA
    Qual Life Res; 2023 May; 32(5):1319-1327. PubMed ID: 35821174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alopecia areata: Clinical presentation, diagnosis, and unusual cases.
    Finner AM
    Dermatol Ther; 2011; 24(3):348-54. PubMed ID: 21689244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brigham Eyebrow Tool for Alopecia: A Reliable Assessment of Eyebrow Alopecia Areata.
    Tkachenko E; Huang KP; Ko JM; Liu KJ; Scott DA; Senna MM; Li SJ; Joyce CJ; Mostaghimi A
    J Investig Dermatol Symp Proc; 2020 Nov; 20(1):S41-S44. PubMed ID: 33099383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bimatoprost versus Mometasone Furoate in the Treatment of Scalp Alopecia Areata: A Pilot Study.
    Zaher H; Gawdat HI; Hegazy RA; Hassan M
    Dermatology; 2015; 230(4):308-13. PubMed ID: 25765294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A qualitative interview study to explore adolescents' experience of alopecia areata and the content validity of sign/symptom patient-reported outcome measures.
    Macey J; Kitchen H; Aldhouse NVJ; Edson-Heredia E; Burge R; Prakash A; King BA; Mesinkovska N
    Br J Dermatol; 2022 May; 186(5):849-860. PubMed ID: 34811721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of the Scalp Hair Assessment PRO™ measure for alopecia areata.
    Wyrwich KW; Kitchen H; Knight S; Aldhouse NVJ; Macey J; Nunes FP; Dutronc Y; Mesinkovska N; Ko JM; King BA
    Br J Dermatol; 2020 Dec; 183(6):1065-1072. PubMed ID: 32163589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors.
    Paggioli I; Moss J
    J Autoimmun; 2022 Dec; 133():102926. PubMed ID: 36335798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of latanoprost 0.005% solution in the management of scalp alopecia areata, a randomized double-blind placebo-controlled trial.
    Rafati M; Mahmoudian R; Golpour M; Kazeminejad A; Saeedi M; Nekoukar Z
    Dermatol Ther; 2022 Jun; 35(6):e15450. PubMed ID: 35289043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular retinol-binding protein-1 expression increases with increasing clinical severity of alopecia areata.
    Elmaadawy E; Elgarhy LH; Shareef M
    J Cosmet Dermatol; 2019 Apr; 18(2):659-664. PubMed ID: 30556317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automating Hair Loss Labels for Universally Scoring Alopecia From Images: Rethinking Alopecia Scores.
    Gudobba C; Mane T; Bayramova A; Rodriguez N; Castelo-Soccio L; Ogunleye TA; Taylor SC; Cotsarelis G; Bernardis E
    JAMA Dermatol; 2023 Feb; 159(2):143-150. PubMed ID: 36515962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric severity of alopecia tool.
    Bernardis E; Nukpezah J; Li P; Christensen T; Castelo-Soccio L
    Pediatr Dermatol; 2018 Jan; 35(1):e68-e69. PubMed ID: 29105836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.